TNFSF10 and esophageal squamous cell carcinoma: The anti-tumor activity of the combination treatment with CPP and AAV-TRAIL was comparable to cisplatin, a chemotherapeutic drug used clinically in ESCC treatment (Fig. 7a-c and Additional file 1: Figure S8A).